Modeling the impact of alternative strategies for rapid molecular diagnosis of tuberculosis in Southeast Asia

Amanda Y. Sun, Madhukar Pai, Henrik Salje, Srinath Satyanarayana, Sarang Deo, David Wesley Dowdy

Research output: Contribution to journalArticle

Abstract

Novel diagnostic tests hold promise for improving tuberculosis (TB) control, but their epidemiologic impact remains uncertain. Using data from the World Health Organization (2011-2012), we developed a transmission model to evaluate the deployment of 3 hypothetical TB diagnostic tests in Southeast Asia under idealized scenarios of implementation. We defined diagnostics by their sensitivity for smear-negative TB and proportion of patients testing positive who initiate therapy ("point-of-care amenability"), with tests of increasing point-of-care amenability having lower sensitivity. Implemented in the public sector (35% of care-seeking attempts), each novel test reduced TB incidence by 7%-9% (95% uncertainty range: 4%-13%) and mortality by 20%-22% (95% uncertainty range: 14%-27%) after 10 years. If also deployed in the private sector (65% of attempts), these tests reduced incidence by 13%-16%, whereas a perfect test (100% sensitivity and treatment initiation) reduced incidence by 20%. Annually detecting 20% of prevalent TB cases through targeted screening (70% smear-negative sensitivity, 85% treatment initiation) also reduced incidence by 19%. Sensitivity and point-of-care amenability are equally important considerations when developing novel diagnostic tests for TB. Novel diagnostics can substantially reduce TB incidence and mortality in Southeast Asia but are unlikely to transform TB control unless they are deployed actively and in the private sector.

Original languageEnglish (US)
Pages (from-to)1740-1749
Number of pages10
JournalAmerican Journal of Epidemiology
Volume178
Issue number12
DOIs
StatePublished - Dec 2013

Fingerprint

Southeastern Asia
Tuberculosis
Point-of-Care Systems
Routine Diagnostic Tests
Incidence
Private Sector
Uncertainty
Mortality
Public Sector
Therapeutics

Keywords

  • Diagnostic techniques and procedures
  • Epidemiologic methods
  • Southeast Asia
  • Theoretical models
  • Tuberculosis

ASJC Scopus subject areas

  • Epidemiology

Cite this

Modeling the impact of alternative strategies for rapid molecular diagnosis of tuberculosis in Southeast Asia. / Sun, Amanda Y.; Pai, Madhukar; Salje, Henrik; Satyanarayana, Srinath; Deo, Sarang; Dowdy, David Wesley.

In: American Journal of Epidemiology, Vol. 178, No. 12, 12.2013, p. 1740-1749.

Research output: Contribution to journalArticle

Sun, Amanda Y. ; Pai, Madhukar ; Salje, Henrik ; Satyanarayana, Srinath ; Deo, Sarang ; Dowdy, David Wesley. / Modeling the impact of alternative strategies for rapid molecular diagnosis of tuberculosis in Southeast Asia. In: American Journal of Epidemiology. 2013 ; Vol. 178, No. 12. pp. 1740-1749.
@article{6a335b717ffd46f088bc9c4b6a01d127,
title = "Modeling the impact of alternative strategies for rapid molecular diagnosis of tuberculosis in Southeast Asia",
abstract = "Novel diagnostic tests hold promise for improving tuberculosis (TB) control, but their epidemiologic impact remains uncertain. Using data from the World Health Organization (2011-2012), we developed a transmission model to evaluate the deployment of 3 hypothetical TB diagnostic tests in Southeast Asia under idealized scenarios of implementation. We defined diagnostics by their sensitivity for smear-negative TB and proportion of patients testing positive who initiate therapy ({"}point-of-care amenability{"}), with tests of increasing point-of-care amenability having lower sensitivity. Implemented in the public sector (35{\%} of care-seeking attempts), each novel test reduced TB incidence by 7{\%}-9{\%} (95{\%} uncertainty range: 4{\%}-13{\%}) and mortality by 20{\%}-22{\%} (95{\%} uncertainty range: 14{\%}-27{\%}) after 10 years. If also deployed in the private sector (65{\%} of attempts), these tests reduced incidence by 13{\%}-16{\%}, whereas a perfect test (100{\%} sensitivity and treatment initiation) reduced incidence by 20{\%}. Annually detecting 20{\%} of prevalent TB cases through targeted screening (70{\%} smear-negative sensitivity, 85{\%} treatment initiation) also reduced incidence by 19{\%}. Sensitivity and point-of-care amenability are equally important considerations when developing novel diagnostic tests for TB. Novel diagnostics can substantially reduce TB incidence and mortality in Southeast Asia but are unlikely to transform TB control unless they are deployed actively and in the private sector.",
keywords = "Diagnostic techniques and procedures, Epidemiologic methods, Southeast Asia, Theoretical models, Tuberculosis",
author = "Sun, {Amanda Y.} and Madhukar Pai and Henrik Salje and Srinath Satyanarayana and Sarang Deo and Dowdy, {David Wesley}",
year = "2013",
month = "12",
doi = "10.1093/aje/kwt210",
language = "English (US)",
volume = "178",
pages = "1740--1749",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Modeling the impact of alternative strategies for rapid molecular diagnosis of tuberculosis in Southeast Asia

AU - Sun, Amanda Y.

AU - Pai, Madhukar

AU - Salje, Henrik

AU - Satyanarayana, Srinath

AU - Deo, Sarang

AU - Dowdy, David Wesley

PY - 2013/12

Y1 - 2013/12

N2 - Novel diagnostic tests hold promise for improving tuberculosis (TB) control, but their epidemiologic impact remains uncertain. Using data from the World Health Organization (2011-2012), we developed a transmission model to evaluate the deployment of 3 hypothetical TB diagnostic tests in Southeast Asia under idealized scenarios of implementation. We defined diagnostics by their sensitivity for smear-negative TB and proportion of patients testing positive who initiate therapy ("point-of-care amenability"), with tests of increasing point-of-care amenability having lower sensitivity. Implemented in the public sector (35% of care-seeking attempts), each novel test reduced TB incidence by 7%-9% (95% uncertainty range: 4%-13%) and mortality by 20%-22% (95% uncertainty range: 14%-27%) after 10 years. If also deployed in the private sector (65% of attempts), these tests reduced incidence by 13%-16%, whereas a perfect test (100% sensitivity and treatment initiation) reduced incidence by 20%. Annually detecting 20% of prevalent TB cases through targeted screening (70% smear-negative sensitivity, 85% treatment initiation) also reduced incidence by 19%. Sensitivity and point-of-care amenability are equally important considerations when developing novel diagnostic tests for TB. Novel diagnostics can substantially reduce TB incidence and mortality in Southeast Asia but are unlikely to transform TB control unless they are deployed actively and in the private sector.

AB - Novel diagnostic tests hold promise for improving tuberculosis (TB) control, but their epidemiologic impact remains uncertain. Using data from the World Health Organization (2011-2012), we developed a transmission model to evaluate the deployment of 3 hypothetical TB diagnostic tests in Southeast Asia under idealized scenarios of implementation. We defined diagnostics by their sensitivity for smear-negative TB and proportion of patients testing positive who initiate therapy ("point-of-care amenability"), with tests of increasing point-of-care amenability having lower sensitivity. Implemented in the public sector (35% of care-seeking attempts), each novel test reduced TB incidence by 7%-9% (95% uncertainty range: 4%-13%) and mortality by 20%-22% (95% uncertainty range: 14%-27%) after 10 years. If also deployed in the private sector (65% of attempts), these tests reduced incidence by 13%-16%, whereas a perfect test (100% sensitivity and treatment initiation) reduced incidence by 20%. Annually detecting 20% of prevalent TB cases through targeted screening (70% smear-negative sensitivity, 85% treatment initiation) also reduced incidence by 19%. Sensitivity and point-of-care amenability are equally important considerations when developing novel diagnostic tests for TB. Novel diagnostics can substantially reduce TB incidence and mortality in Southeast Asia but are unlikely to transform TB control unless they are deployed actively and in the private sector.

KW - Diagnostic techniques and procedures

KW - Epidemiologic methods

KW - Southeast Asia

KW - Theoretical models

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=84887389907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887389907&partnerID=8YFLogxK

U2 - 10.1093/aje/kwt210

DO - 10.1093/aje/kwt210

M3 - Article

C2 - 24100953

AN - SCOPUS:84887389907

VL - 178

SP - 1740

EP - 1749

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 12

ER -